Source: StreetInsider

Press Release: Soligenix : Soligenix Inc. (NASDAQ: SNGX) Featured in Virtual Coverage of the Fall Investor Summit 2020

Soligenix Inc. (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Its Specialized BioTherapeutics business segment is...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Christopher J. Schaber's photo - Chairman & CEO of Soligenix

Chairman & CEO

Christopher J. Schaber

CEO Approval Rating

88/100

Soligenix is a late-stage biopharmaceutical company that researches and develops novel vaccines for the treatment of cancer and infectious diseases. Read more